BR112017016295A2 - caracterização simultânea de anticorpos igg e iga para múltiplos antígenos alimentares e complexos imunes de proteína alimentar c1q - Google Patents

caracterização simultânea de anticorpos igg e iga para múltiplos antígenos alimentares e complexos imunes de proteína alimentar c1q

Info

Publication number
BR112017016295A2
BR112017016295A2 BR112017016295A BR112017016295A BR112017016295A2 BR 112017016295 A2 BR112017016295 A2 BR 112017016295A2 BR 112017016295 A BR112017016295 A BR 112017016295A BR 112017016295 A BR112017016295 A BR 112017016295A BR 112017016295 A2 BR112017016295 A2 BR 112017016295A2
Authority
BR
Brazil
Prior art keywords
food
igg
immune complexes
iga antibodies
antigens
Prior art date
Application number
BR112017016295A
Other languages
English (en)
Inventor
Vojdani Aristo
Original Assignee
Cyrex Laboratories Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cyrex Laboratories Llc filed Critical Cyrex Laboratories Llc
Publication of BR112017016295A2 publication Critical patent/BR112017016295A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

trata-se de composições e métodos para caracterizar precisamente a reatividade imune a alergênicos alimentares que foram desenvolvidas, nas quais superfícies de teste que incorporam preparações de antígeno alimentar diferentes derivadas do mesmo alimento em locais de teste individuais são fornecidas. tais superfícies revestidas podem ser produzidas com o uso de alimentos crus e cozidos. o uso de um painel de tais superfícies de teste para distinguir ligação de igg, iga e/ou c1q específica fornece sensibilidade melhorada e precisão na determinação de reatividade imune e resposta a alimentos específicos.
BR112017016295A 2015-01-30 2015-01-30 caracterização simultânea de anticorpos igg e iga para múltiplos antígenos alimentares e complexos imunes de proteína alimentar c1q BR112017016295A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/609,865 US9562911B2 (en) 2015-01-30 2015-01-30 Simultaneous characterization of IgG and IgA antibodies to multiple food antigens and C1Q-food protein immune complexes
PCT/US2015/013770 WO2016122597A1 (en) 2015-01-30 2015-01-30 Simultaneous characterization of igg and iga antibodies to multiple food antigens and c1q-food protein immune complexes

Publications (1)

Publication Number Publication Date
BR112017016295A2 true BR112017016295A2 (pt) 2018-03-27

Family

ID=52597255

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017016295A BR112017016295A2 (pt) 2015-01-30 2015-01-30 caracterização simultânea de anticorpos igg e iga para múltiplos antígenos alimentares e complexos imunes de proteína alimentar c1q

Country Status (11)

Country Link
US (1) US9562911B2 (pt)
EP (1) EP3250926B1 (pt)
JP (1) JP6594985B2 (pt)
KR (1) KR102332418B1 (pt)
CN (1) CN107750336B (pt)
AU (1) AU2015380551B9 (pt)
BR (1) BR112017016295A2 (pt)
CA (1) CA2975230C (pt)
IL (2) IL253725B (pt)
RU (1) RU2687976C2 (pt)
WO (1) WO2016122597A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108700595A (zh) * 2015-12-21 2018-10-23 拜尔梅里科有限公司 银屑病食物敏感测试的组合物、设备以及方法
CA3047375A1 (en) * 2015-12-21 2017-06-29 Biomerica, Inc. Compositions, devices, and methods of migraine headache food sensitivity testing
WO2017156313A1 (en) * 2016-03-09 2017-09-14 Biomerica, Inc. Compositions, devices, and methods of functional dyspepsia sensitivity testing
BR102017027544A2 (pt) * 2017-12-20 2021-11-09 Fundação Universidade Estadual Do Ceará - Funece Kit e processo para detecção de imunoglobulinas e e imunoglobulinas g1

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2263063C (en) * 1999-02-26 2004-08-10 Skye Pharmatech Incorporated Method for diagnosing and distinguishing stroke and diagnostic devices for use therein
CN102993299B (zh) * 2001-09-05 2017-04-12 日本肉类批发商株式会社 食物致敏原，检测食物过敏原的方法和检测诱导食物过敏原的食物的方法
JP2003129083A (ja) 2001-10-18 2003-05-08 Takahiro Ishikawa 糖脂質の分離方法
GB0325038D0 (en) 2003-10-27 2003-12-03 Ares Trading Sa Protein
US20090010937A1 (en) 2004-01-28 2009-01-08 Chauhan Anil K Membrane Attack Complexes Associated with Circulating Immune Complexes
US8309318B2 (en) * 2004-02-10 2012-11-13 Brendan Bioscience, Llc Detection of antigen specific immunocomplexes
US20050255533A1 (en) * 2004-02-10 2005-11-17 Brendan Bioscience, Llc Comprehensive food allergy test
WO2010110454A1 (ja) * 2009-03-26 2010-09-30 国立大学法人名古屋大学 アレルギー疾患の診断方法
JP5563435B2 (ja) * 2010-11-24 2014-07-30 エア・ウォーター株式会社 酸素濃縮装置
CN102539748A (zh) * 2011-12-30 2012-07-04 苏州浩欧博生物医药有限公司 一种利用酶联板进行多指标酶联免疫吸附检测的方法

Also Published As

Publication number Publication date
RU2687976C2 (ru) 2019-05-17
KR20170129712A (ko) 2017-11-27
AU2015380551A1 (en) 2017-08-17
CA2975230C (en) 2023-02-21
US20160320403A1 (en) 2016-11-03
US9562911B2 (en) 2017-02-07
JP6594985B2 (ja) 2019-10-23
IL253725B (en) 2020-11-30
IL278627B (en) 2021-09-30
CN107750336B (zh) 2019-12-13
JP2018504602A (ja) 2018-02-15
EP3250926A1 (en) 2017-12-06
RU2017128169A3 (pt) 2019-03-01
CN107750336A (zh) 2018-03-02
AU2015380551B9 (en) 2021-11-25
IL253725A0 (en) 2017-09-28
KR102332418B1 (ko) 2021-11-26
AU2015380551B2 (en) 2021-07-29
EP3250926B1 (en) 2019-10-16
RU2017128169A (ru) 2019-03-01
CA2975230A1 (en) 2016-08-04
WO2016122597A1 (en) 2016-08-04

Similar Documents

Publication Publication Date Title
CY1124472T1 (el) Κατασκευασματα διειδικων αντισωματων που δεσμευουν dll3 και cd3
CL2018000378A1 (es) Receptores de antígenos quiméricos basados en anticuerpos de dominio simple y métodos de uso de estos
BR112016014022A2 (pt) anticorpos anti-cd3, ácido nucleico isolado, vetor, célula hospedeira, método de produção do anticorpo anti-cd3, imunoconjugado, composição, uso do anticorpo anti-cd3, métodos de tratamento, métodos de intensificação da função imune e kit
BR122022002481A8 (pt) Anticorpos biespecíficos de ligação específica para cd3delta-epsilon
BR112018070823A2 (pt) anticorpo sirpa anti-humano ou fragmento de ligação a antígeno do mesmo ou mimético de anticorpo de ligação a antígeno, composição farmacêutica, produto de combinação, molécula de ácido nucleico isolada, vetor, célula hospedeira isolada, polipeptídeo, métodos para fabricar um anticorpo, in vitro ou ex vivo para determinar células positivas para sirpa, de diagnóstico e para prever a resposta de um sujeito, e, uso de um anticorpo anti-sirpa ou um fragmento de ligação a antígeno do mesmo ou um mimético de ligação a anticorpo e in vitro ou ex vivo de pelo menos um anticorpo sirpa anti-humano ou fragmento de ligação a antígeno do mesmo ou mimético de anticorpo de ligação a antígeno.
CL2023000896A1 (es) Receptores quiméricos de dll3 y métodos para su uso
BR112018005862A2 (pt) anticorpos, anticorpos isolados, polinucleotídeo, vetor, célula hospedeira, método de produção do anticorpo, imunoconjugado, composição, usos dos anticorpos, métodos para tratar ou retardar a progressão de um câncer e de uma doença e para aumentar, potencializar ou estimular uma resposta ou função imune e kit
MX2022011659A (es) Proteinas de union a antigeno que se unen a pd-l1.
BR112019011186A2 (pt) conjugado de anticorpo radiomarcado, composto, e, métodos de imageamento e para tratamento de um tumor.
EA201891435A1 (ru) Гуманизированные моноклональные антитела, моноклональные антитела мыши или химерные моноклональные антитела против cd47
BR112016029372A2 (pt) anticorpo isolado ou fragmento de ligação de antígeno do mesmo, molécula de ácido nucleico isolado, vetor, métodos para produzir um anticorpo isolado ou fragmento de ligação de antígeno do mesmo, para preparar um conjugado e para aliviar um sintoma de um câncer, conjugado, e, uso de um conjugado.
WO2017075432A3 (en) Anti-siglec-9 antibodies and methods of use thereof
WO2017152102A3 (en) Anti-trem1 antibodies and methods of use thereof
BR112017027254A2 (pt) anticorpos anti-cd123 e conjugados e derivados dos mesmos
BR112017016295A2 (pt) caracterização simultânea de anticorpos igg e iga para múltiplos antígenos alimentares e complexos imunes de proteína alimentar c1q
MX2018012651A (es) Composiciones que comprenden coformulacion de anticuerpos anti-ligando-1 de muerte celular programada (pd-l1) y anti-antigeno-4 asociado a linfocitos t citotoxicos (ctla-4).
MX2015012540A (es) Ratón de cadena ligera común.
WO2019060750A3 (en) A33 antibody compositions and methods of using the same in radioimmunotherapy
BR112022018088A2 (pt) Novos anticorpos anti-lilrb4 e produtos derivados
MX2018009738A (es) Anticuerpos monoclonales de proteína ns1 anti-virus del dengue.
BR112017006598A2 (pt) anticorpo de repetições antidipeptídeo derivado de ser humano (dprs)
BR112018071686A2 (pt) exibição de proteínas integrais de membrana em vírions extracelulares envelopados de poxvírus
BR112016017764A2 (pt) anticorpo antidengue de amplo espectro
WO2017062496A3 (en) Anti-sas1b antibodies, associated methods of use, and compositions and methods for detecting and treating cancer
BR112016029935A2 (pt) ?anticorpos anti-brdu, complexo, formulação farmacêutica e uso de anticorpo?

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements